Focal adhesion kinase inhibitor BI 853520 inhibits cell proliferation, migration and EMT process through PI3K/AKT/mTOR signaling pathway in ovarian cancer
Abstract Focal adhesion kinase (FAK) activation has been reported to be associated with cell progression and metastasis in a wide variety of cancer cells. Target treatment by inhibiting FAK has achieved remarkable effects in several cancers, but the effect in ovarian cancer has not been reported. In...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer
2021-08-01
|
| Schriftenreihe: | Discover Oncology |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1007/s12672-021-00425-6 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|